UA111158C2 - METHOD OF COMBINED THERAPY FOR TREATMENT OF PROLIFERATIVE DISEASES - Google Patents
METHOD OF COMBINED THERAPY FOR TREATMENT OF PROLIFERATIVE DISEASESInfo
- Publication number
- UA111158C2 UA111158C2 UAA201300241A UAA201300241A UA111158C2 UA 111158 C2 UA111158 C2 UA 111158C2 UA A201300241 A UAA201300241 A UA A201300241A UA A201300241 A UAA201300241 A UA A201300241A UA 111158 C2 UA111158 C2 UA 111158C2
- Authority
- UA
- Ukraine
- Prior art keywords
- treatment
- proliferative diseases
- combined therapy
- azacytidine
- decitabine
- Prior art date
Links
- 238000002648 combination therapy Methods 0.000 title abstract 2
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000002062 proliferating effect Effects 0.000 title abstract 2
- NMUSYJAQQFHJEW-KVTDHHQDSA-N 5-azacytidine Chemical compound O=C1N=C(N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 NMUSYJAQQFHJEW-KVTDHHQDSA-N 0.000 abstract 2
- 229960002756 azacitidine Drugs 0.000 abstract 2
- XAUDJQYHKZQPEU-KVQBGUIXSA-N 5-aza-2'-deoxycytidine Chemical compound O=C1N=C(N)N=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 XAUDJQYHKZQPEU-KVQBGUIXSA-N 0.000 abstract 1
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 229930012538 Paclitaxel Natural products 0.000 abstract 1
- 229960003603 decitabine Drugs 0.000 abstract 1
- 239000002105 nanoparticle Substances 0.000 abstract 1
- 229960001592 paclitaxel Drugs 0.000 abstract 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Винахід стосується способу комбінованої терапії для лікування проліферативного захворювання, що включає введення індивідууму композиції, що містить наночастинки, які містять паклітаксел і альбумін, та ефективної кількості щонайменше одного іншого засобу, вибраного з децитабіну і азацитидину, причому азацитидин придатний для орального введення.The invention relates to a method of combination therapy for the treatment of proliferative disease, comprising administering to the individual a composition comprising nanoparticles containing paclitaxel and albumin, and an effective amount of at least one other agent selected from decitabine and azacytidine, including azacitidine.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35233310P | 2010-06-07 | 2010-06-07 | |
| PCT/US2011/037450 WO2011156119A1 (en) | 2010-06-07 | 2011-05-20 | Combination therapy methods for treating proliferative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA111158C2 true UA111158C2 (en) | 2016-04-11 |
Family
ID=55861968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201300241A UA111158C2 (en) | 2010-06-07 | 2011-05-20 | METHOD OF COMBINED THERAPY FOR TREATMENT OF PROLIFERATIVE DISEASES |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA111158C2 (en) |
-
2011
- 2011-05-20 UA UAA201300241A patent/UA111158C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI201200181A (en) | COMBINED THERAPY METHODS TO TREAT PROLIFERATIVE DISEASES | |
| CO6670567A2 (en) | Methods of treatment against pancreatic cancer | |
| MX359413B (en) | Methods of treatment of hepatocellular carcinoma. | |
| MX380318B (en) | NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS AN ANTI-CANCER AGENT. | |
| BR112012024590A2 (en) | methods of enhancing drug release and efficacy of therapeutic agents | |
| SG10201804552WA (en) | Nanoparticle compositions, formulations thereof, and uses therefor | |
| UA109991C2 (en) | CARBAMATE COMPOUNDS, THEIR PREPARATION AND APPLICATION | |
| BRPI0809164B8 (en) | COMPOSITION FOR TOPICAL ADMINISTRATION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID COMPOSITION | |
| CR20120528A (en) | METHODS TO TREAT CANCER | |
| WO2010011609A3 (en) | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | |
| IN2012DN02018A (en) | ||
| HN2012000023A (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES | |
| WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
| BR112014010376A2 (en) | medicament for treating anterior eye disease comprising rebamipide and a tear retention agent | |
| MX2016002408A (en) | Treatment of pediatric otic disorders. | |
| BR112013003064A2 (en) | prophylactic or therapeutic agent for non-alcoholic steatohepatitis | |
| BR112014032264A8 (en) | Composition for the treatment or prevention of diseases related to vascular permeability, containing imatinib or a pharmaceutically acceptable salt thereof as an active ingredient | |
| UA111158C2 (en) | METHOD OF COMBINED THERAPY FOR TREATMENT OF PROLIFERATIVE DISEASES | |
| HK1183814A (en) | Combination therapy methods for treating proliferative diseases | |
| MX2014003264A (en) | Cosmetic use of hesperidin or a derivative thereof in the prevention and/or treatment of body odour. | |
| HK1183815A (en) | Methods of treatment of pancreatic cancer | |
| UA112448C2 (en) | COMPOSITION AND METHOD OF TREATMENT OF AUTO-IMMUNE DISEASE | |
| HK1181667A (en) | Methods of enhancing drug delivery and effectiveness of therapeutic agents | |
| BR112015002384A8 (en) | pharmaceutical combinations comprising a b-raf inhibitor, an egfr inhibitor and, optionally, a pi3k-alpha inhibitor, and their uses. | |
| TH149179A (en) | Pharmaceutical compositions, pharmaceutical forms, processes for preparing such compositions and forms, methods of treatment and use of such compositions and forms. |